109 related articles for article (PubMed ID: 24720128)
1. [Reccurent mycobacterial diseases in patients with impaired axis IL-12/INF-gamma].
Strach M; Nalepa P; Sulicka-Grodzicka J; Kierzkowska I; Siedlar M; Grodzicki T
Przegl Lek; 2013; 70(12):1058-60. PubMed ID: 24720128
[TBL] [Abstract][Full Text] [Related]
2. [Genetic predisposition and susceptibility to mycobacterial infections: the IL-12-IFNgamma axis deficiency].
Picard C; Casanova JL
Rev Med Brux; 2005 Feb; 26(1):17-9. PubMed ID: 15816335
[TBL] [Abstract][Full Text] [Related]
3. Immune defects in active mycobacterial diseases in patients with primary immunodeficiency diseases (PIDs).
Lee WI; Huang JL; Yeh KW; Jaing TH; Lin TY; Huang YC; Chiu CH
J Formos Med Assoc; 2011 Dec; 110(12):750-8. PubMed ID: 22248828
[TBL] [Abstract][Full Text] [Related]
4. Human nuclear factor kappa B essential modulator mutation can result in immunodeficiency without ectodermal dysplasia.
Orange JS; Levy O; Brodeur SR; Krzewski K; Roy RM; Niemela JE; Fleisher TA; Bonilla FA; Geha RS
J Allergy Clin Immunol; 2004 Sep; 114(3):650-6. PubMed ID: 15356572
[TBL] [Abstract][Full Text] [Related]
5. Impaired interferon gamma-mediated immunity and susceptibility to mycobacterial infection in childhood.
Remus N; Reichenbach J; Picard C; Rietschel C; Wood P; Lammas D; Kumararatne DS; Casanova JL
Pediatr Res; 2001 Jul; 50(1):8-13. PubMed ID: 11420412
[TBL] [Abstract][Full Text] [Related]
6. Correlating interleukin-12 stimulated interferon-γ production and the absence of ectodermal dysplasia and anhidrosis (EDA) in patients with mutations in NF-κB essential modulator (NEMO).
Haverkamp MH; Marciano BE; Frucht DM; Jain A; van de Vosse E; Holland SM
J Clin Immunol; 2014 May; 34(4):436-43. PubMed ID: 24682681
[TBL] [Abstract][Full Text] [Related]
7. Heritable defects of the human TLR signalling pathways.
Puel A; Yang K; Ku CL; von Bernuth H; Bustamante J; Santos OF; Lawrence T; Chang HH; Al-Mousa H; Picard C; Casanova JL
J Endotoxin Res; 2005; 11(4):220-4. PubMed ID: 16176658
[TBL] [Abstract][Full Text] [Related]
8. Genetic dissection of immunity to mycobacteria: the human model.
Casanova JL; Abel L
Annu Rev Immunol; 2002; 20():581-620. PubMed ID: 11861613
[TBL] [Abstract][Full Text] [Related]
9. [Mendelian susceptibility to mycobacterial disease: defects in the IL-12/IFNgamma pathway].
Fieschi C
Presse Med; 2006 May; 35(5 Pt 2):879-86. PubMed ID: 16710161
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic transplantation successfully corrects immune defects, but not susceptibility to colitis, in a patient with nuclear factor-kappaB essential modulator deficiency.
Pai SY; Levy O; Jabara HH; Glickman JN; Stoler-Barak L; Sachs J; Nurko S; Orange JS; Geha RS
J Allergy Clin Immunol; 2008 Dec; 122(6):1113-1118.e1. PubMed ID: 18851875
[TBL] [Abstract][Full Text] [Related]
11. The role of interleukin-12 in human infectious diseases: only a faint signature.
Fieschi C; Casanova JL
Eur J Immunol; 2003 Jun; 33(6):1461-4. PubMed ID: 12778462
[TBL] [Abstract][Full Text] [Related]
12. Interferon gamma, IL-12, IL-12R and STAT-1 immunodeficiency diseases: disorders of the interface of innate and adaptive immunity.
Holland SM
Immunol Res; 2007; 38(1-3):342-6. PubMed ID: 17917041
[TBL] [Abstract][Full Text] [Related]
13. Genetic determinants of susceptibility to Mycobacterial infections: IRF8, a new kid on the block.
Salem S; Gros P
Adv Exp Med Biol; 2013; 783():45-80. PubMed ID: 23468103
[TBL] [Abstract][Full Text] [Related]
14. Control of human host immunity to mycobacteria.
Ottenhoff TH; Verreck FA; Hoeve MA; van de Vosse E
Tuberculosis (Edinb); 2005; 85(1-2):53-64. PubMed ID: 15687028
[TBL] [Abstract][Full Text] [Related]
15. Human immunodeficiencies that predispose to intracellular bacterial infections.
Doffinger R; Patel S; Kumararatne DS
Curr Opin Rheumatol; 2005 Jul; 17(4):440-6. PubMed ID: 15956841
[TBL] [Abstract][Full Text] [Related]
16. Severe disseminated mycobacterial infection in a boy with a novel mutation leading to IFN-γR2 deficiency.
Kilic SS; van Wengen A; de Paus RA; Celebi S; Meziane B; Hafizoglu D; van Dissel JT; van de Vosse E
J Infect; 2012 Dec; 65(6):568-72. PubMed ID: 22902943
[TBL] [Abstract][Full Text] [Related]
17. Human host defense and cytokines in mycobacterial infectious diseases: interleukin-18 cannot compensate for genetic defects in the interleukin-12 system.
Verreck FA; de Boer T; Hoeve M; van Dissel JT; Sanal O; Kurimoto M; Ottenhoff TH
Clin Infect Dis; 2002 Jul; 35(2):210-2. PubMed ID: 12087531
[No Abstract] [Full Text] [Related]
18. Interferon-gamma reduces the proliferation of M. tuberculosis within macrophages from a patient with a novel hypomorphic NEMO mutation.
Khan TA; Schimke LF; Amaral EP; Ishfaq M; Barbosa Bonfim CC; Rahman H; Iqbal A; D'Império Lima MR; Costa Carvalho BT; Cabral-Marques O; Condino-Neto A
Pediatr Blood Cancer; 2016 Oct; 63(10):1863-6. PubMed ID: 27391872
[TBL] [Abstract][Full Text] [Related]
19. [Mendelian susceptibility to mycobacterial infections and defect in macrophages respiratory burst].
Bustamante J
Med Sci (Paris); 2011; 27(6-7):579-81. PubMed ID: 21718638
[No Abstract] [Full Text] [Related]
20. NEMO mutations in 2 unrelated boys with severe infections and conical teeth.
Ku CL; Dupuis-Girod S; Dittrich AM; Bustamante J; Santos OF; Schulze I; Bertrand Y; Couly G; Bodemer C; Bossuyt X; Picard C; Casanova JL
Pediatrics; 2005 May; 115(5):e615-9. PubMed ID: 15833888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
